Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniel Zibly"'
Autor:
Noam Barda, Yaniv Lustig, Victoria Indenbaum, Daniel Zibly, Gili Joseph, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Limor Kliker, Bayan Abd Elkader, Eytan Ben-Ami, Michal Canetti, Ravit Koren, Shiri Katz-Likvornik, Osnat Halpern, Ella Mendelson, Ram Doolman, Dror Harats, Yitshak Kreiss, Michal Mandelboim, Gili Regev-Yochay
Publikováno v:
Clinical Microbiology and Infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daf09c3eaadccd984940982e798f9f3f
https://doi.org/10.1016/j.cmi.2023.03.007
https://doi.org/10.1016/j.cmi.2023.03.007
Autor:
Noam Barda, Michal Canetti, Mayan Gilboa, Victoria Indenboim, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Daniel Zibly, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S. Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 27(39)
We assess the immunogenicity and efficacy of Spikevax and Comirnaty as fourth dose COVID-19 vaccines. Six months post-fourth-dose, IgG levels were higher than pre-fourth dose at 1.58-fold (95% CI: 1.27–1.97) in Spikevax and 1.16-fold (95% CI: 0.98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39c1e9f3cdd04c89fd29907eba3e2fd
https://pubmed.ncbi.nlm.nih.gov/36177870
https://pubmed.ncbi.nlm.nih.gov/36177870